Exploring the Prognostic Role of Ki67 Proliferative Index in Merkel Cell Carcinoma of the Skin: Clinico-Pathologic Analysis of 84 Cases and Review of the Literature
Open Access
- 22 July 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Endocrine Pathology
- Vol. 31 (4), 392-400
- https://doi.org/10.1007/s12022-020-09640-3
Abstract
The exact prediction of outcome of patients with Merkel cell carcinoma (MCC) of the skin is difficult to determine, although several attempts have been made to identify clinico-pathologic prognostic factors. The Ki67 proliferative index is a well-known marker routinely used to define the prognosis of patients with neuroendocrine neoplasms. However, its prognostic value has been poorly investigated in MCC, and available published results are often contradictory mainly because restricted to small series in the absence of standardized methods for Ki67 evaluation. For this reason, we explored the potential prognostic role of Ki67 proliferative index in a large series of MCCs using the WHO standardized method of counting positive cells in at least 500 tumor cells in hot spot areas on camera-captured printed images. In addition, since MCC may be considered as the cutaneous counterpart of digestive neuroendocrine carcinomas (NECs), we decided to stratify MCCs using the available and efficient Ki67 threshold of 55%, which was found prognostic in digestive NECs. This choice was also supported by the Youden index analysis. In addition, we analyzed the prognostic value of other clinico-pathologic parameters using both univariate and multivariate analysis. Ki67 index appeared significantly associated with prognosis at univariate analysis together with stage IV, lack of MCPyV, and p63 expression, but not at the multivariate analysis, where survival resulted independently influenced by p63 expression and tumor stage, only.Funding Information
- University of Lausanne
This publication has 44 references indexed in Scilit:
- Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC studyAnnals of Oncology, 2012
- Merkel Cell Polyomavirus Infection, Large T Antigen, Retinoblastoma Protein and Outcome in Merkel Cell CarcinomaClinical Cancer Research, 2011
- Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging systemJournal of the American Academy of Dermatology, 2010
- Merkel cell carcinomaCancer, 2008
- Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinomaLaboratory Investigation, 2008
- Differential kinetic features by tumour topography in cutaneous small‐cell neuroendocrine (Merkel cell) carcinomasJournal of the European Academy of Dermatology and Venereology, 2007
- Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinomaJournal of the European Academy of Dermatology and Venereology, 2006
- Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinomaHistopathology, 2005
- Merkel cell carcinoma: a clinicopathological study of 11 casesJournal of the European Academy of Dermatology and Venereology, 2005
- Multimodality Treatment of Merkel Cell Carcinoma: Case Series and Literature Review of 1024 CasesAnnals of Surgical Oncology, 2001